{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "NANEXA AB", "longName": "Nanexa AB (publ)", "messageBoardId": "finmb_300503236", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 3.6101048, "regularMarketPrice": 0.287, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.21798368, "fiftyTwoWeekLow": 0.0943, "fiftyTwoWeekHigh": 0.367, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.08, "sharesOutstanding": 60695600, "fiftyDayAverage": 0.31942, "fiftyDayAverageChange": -0.03242001, "fiftyDayAverageChangePercent": -0.10149649, "twoHundredDayAverage": 0.236774, "twoHundredDayAverageChange": 0.050226003, "twoHundredDayAverageChangePercent": 0.21212634, "marketCap": 18337090, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Nanexa AB", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.00999999, "regularMarketTime": 1683892037, "regularMarketDayHigh": 0.287, "regularMarketDayRange": "0.28 - 0.287", "regularMarketDayLow": 0.28, "regularMarketVolume": 303, "regularMarketPreviousClose": 0.277, "bid": 0.0, "ask": 0.0, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.28, "averageDailyVolume3Month": 5, "averageDailyVolume10Day": 30, "fiftyTwoWeekLowChange": 0.1927, "fiftyTwoWeekLowChangePercent": 2.0434783, "fiftyTwoWeekRange": "0.0943 - 0.367", "fiftyTwoWeekHighChange": -0.08000001, "firstTradeDateMilliseconds": 1613372400000, "symbol": "40M.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Virdings AllE 32B", "city": "Uppsala", "zip": "75450", "country": "Sweden", "phone": "46 18 10 03 00", "website": "https://www.nanexa.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.", "fullTimeEmployees": 19, "companyOfficers": [{"maxAge": 1, "name": "Mr. David  Westberg", "age": 62, "title": "Chief Exec. Officer", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Marten  Rooth", "age": 45, "title": "Co-Founder, Head of R&D Atomic Layer Deposition, CTO and Director", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bengt  Gustavsson M.Sc.", "age": 60, "title": "Medical Director & Director", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Otto  Skolling M.Sc", "age": 61, "title": "Director Bus. Devel. & Director", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Anders  Johansson", "age": 46, "title": "Co-Founder & Head of Intellectual Property", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bj\u00f6rn  Svanstr\u00f6m", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mikael  Asp", "age": 60, "title": "Head of QA & Expert", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Joel  Hellrup", "age": 39, "title": "Head of Pharmaceutical R&D", "yearBorn": 1983, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}